Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Synthorx, Inc., a biopharmaceutical company, focuses on the development of cytokine Synthorin programs for the treatment of cancer and autoimmune disorders in the United States. The company's lead product candidate is THOR-707, a variant of recombinant human IL-2 that is in the development in various solid tumor types as a single agent and in combination with an immune checkpoint inhibitor. It also develops IL-2 Synthorin for autoimmune indications; IL-10 Synthorin, a naturally occurring immune cell growth factor in humans for the treatment of immuno-oncology (IO); and IL-15 Synthorins, an immunoregulatory cytokine to treat IO. In addition, the company develops other Synthorin programs targeting undisclosed cytokines that play critical roles in the orchestration of anti-tumor responses by innate and adaptive immune cells. The company was formerly known as Alinos, Inc. and changed its name to Synthorx, Inc. in March 2014. Synthorx, Inc. was founded in 2014 and is headquartered in La Jolla, California. more
| Time Frame | THOR | S&P500 |
|---|---|---|
| 1-Week Return | - | -0.74% |
| 1-Month Return | - | -1.98% |
| 3-Month Return | - | 12.28% |
| 6-Month Return | - | 6.55% |
| 1-Year Return | - | 20.9% |
| 3-Year Return | - | 69.95% |
| 5-Year Return | - | 72.51% |
| 10-Year Return | 97.54% | 262.53% |
| Time Frame | THOR | S&P500 |
|---|---|---|
| 1-Week Return | 0.00% | -32.11% |
| 1-Month Return | 0.00% | -21.60% |
| 3-Month Return | 0.00% | 59.96% |
| 6-Month Return | 0.00% | 13.73% |
| 1-Year Return | 0.00% | 20.90% |
| 3-Year Return | 0.00% | 19.34% |
| 5-Year Return | 0.00% | 11.52% |
| 10-Year Return | 7.04% | 13.75% |
| Sector | Weight |
|---|---|
|
Health Care
|
100.00% |
Synthorx Inc (THOR) share price today is $24.89.
Yes, Indians can buy shares of Synthorx Inc (THOR) on Vested. To buy THOR from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Synthorx Inc (THOR) on Vested. You can start investing in Synthorx Inc (THOR) with a minimum investment of $1.
The 52-week high price of Synthorx Inc (THOR) is $. The 52-week low price of Synthorx Inc (THOR) is $.
The stock symbol (or ticker) of Synthorx Inc is THOR.
Yes, you can setup SIP in Synthorx Inc shares. Follow the below steps to create the SIP:
Here is the historical performance of THOR on the Vested app.
The expense ratio of Synthorx Inc (THOR) is .
Link copied